AMRX Amneal Pharmaceuticals, Inc.
$21.14▼ -1.40%
Healthcare
Other
After hours
$21.14▲ +0.00%
Oct 28, 4:00 PM ET
Volume 3.30M
Avg Volume (10D) 4.32M
Key Metrics & Fundamentals
Market Cap
$7.36B
P/E Ratio
43.1
Div Yield
0.00%
52W Range
9.99 - 21.67
% vs 50 MA
13.29%
% vs 200 MA
37.28%
RSI-14
69.3
MACD Histogram
+0.1100
Beta (1Y vs SPY)
0.69
Free Cash Flow
-$143.99M
Gross Rev
$796.20M
Gross Profit
$334.51M
EBITDA
$194.43M
COGS
$461.69M
Operating Exp
$188.53M
Operating Income
$145.98M
EBIT
$145.98M
Pretax Income
$70.99M
Net Income
$57.66M
EPS (Diluted)
0.18
Price & Volume History
Loading chart…
Recent News
BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks · Oct 28, 2026 9:00 AM ET
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 27, 2026 9:00 AM ET
Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?
Zacks · Oct 27, 2026 8:40 AM ET
Implied Volatility Surging for Amneal Pharmaceuticals Stock Options
Zacks · Oct 27, 2026 8:00 AM ET
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
Zacks · Oct 26, 2026 11:10 AM ET
Amneal Pharmaceuticals (AMRX) Faces A Valuation Test Following Slowing Growth Concerns
Simply Wall St. · Oct 24, 2026 10:10 AM ET
1 Russell 2000 Stock with Competitive Advantages and 2 Facing Challenges
StockStory · Oct 22, 2026 4:37 PM ET
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
StockStory · Oct 13, 2026 4:03 AM ET
3 Overrated Stocks We Think Twice About
StockStory · Oct 9, 2026 6:59 AM ET
Amneal to Report Third Quarter 2026 Results on November 3, 2026
GlobeNewswire · Oct 8, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AMRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.